Amarin | AMRN - Pre Utilidad Fiscal

Precio De Mercado
14.49
Cambio Diario
-0.51 -3.40%
Mensual
-7.29%
Anual
58.50%
Q1 Expectativa
14.05




Pre Utilidad Fiscal Cambio Fecha
AbbVie USD 4.38B 1.92B 2025-09
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amarin USD -852K 7.26M 2025-12
AstraZeneca USD 3.24B 117M 2025-09
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
DBV Technologies USD -33.16M 8.6M 2025-09
Esperion Therapeutics USD 63.67M 95M 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
Novartis USD 4.64B 445M 2025-12